NO20003522L - Fremgangsmåte og system for å bestemme en virksom mengde av lysenergi å levere til fluider som har target for lysenergien - Google Patents
Fremgangsmåte og system for å bestemme en virksom mengde av lysenergi å levere til fluider som har target for lysenergienInfo
- Publication number
- NO20003522L NO20003522L NO20003522A NO20003522A NO20003522L NO 20003522 L NO20003522 L NO 20003522L NO 20003522 A NO20003522 A NO 20003522A NO 20003522 A NO20003522 A NO 20003522A NO 20003522 L NO20003522 L NO 20003522L
- Authority
- NO
- Norway
- Prior art keywords
- light energy
- deliver
- effective amount
- determining
- fluids
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title abstract 3
- 239000013060 biological fluid Substances 0.000 abstract 1
- 238000001126 phototherapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
- A61M1/3696—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
- A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Radiation-Therapy Devices (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/350,134 US6219584B1 (en) | 1999-07-09 | 1999-07-09 | Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003522D0 NO20003522D0 (no) | 2000-07-07 |
NO20003522L true NO20003522L (no) | 2001-01-10 |
Family
ID=23375376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003522A NO20003522L (no) | 1999-07-09 | 2000-07-07 | Fremgangsmåte og system for å bestemme en virksom mengde av lysenergi å levere til fluider som har target for lysenergien |
Country Status (17)
Country | Link |
---|---|
US (1) | US6219584B1 (de) |
EP (2) | EP1754497B1 (de) |
JP (1) | JP5008788B2 (de) |
CN (1) | CN100354623C (de) |
AT (2) | ATE330648T1 (de) |
CA (1) | CA2313577C (de) |
CZ (1) | CZ302538B6 (de) |
DE (2) | DE60028872T2 (de) |
DK (1) | DK1066842T3 (de) |
ES (2) | ES2265869T3 (de) |
HK (1) | HK1033101A1 (de) |
HU (1) | HUP0002591A2 (de) |
IL (1) | IL137133A (de) |
NO (1) | NO20003522L (de) |
PT (2) | PT1066842E (de) |
SG (1) | SG89337A1 (de) |
TR (1) | TR200001913A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6969367B2 (en) * | 2000-02-02 | 2005-11-29 | Xepmed, Inc. | Extracorporeal pathogen reduction system |
US7470245B2 (en) * | 2000-02-02 | 2008-12-30 | Xepmed, Inc. | Extracorporeal pathogen reduction system |
CA2475021A1 (en) * | 2001-01-31 | 2002-08-08 | Dror Mevorach | Induction of tolerance by apoptotic and/or necrotic cells |
US20050202098A1 (en) * | 2001-01-31 | 2005-09-15 | Tolaren | Disease therapy using dying or dead cells |
US20030139466A1 (en) | 2001-11-29 | 2003-07-24 | Peritt David L. | Methods for pretreating a subject with extracorporeal photopheresis |
US7479123B2 (en) * | 2002-03-04 | 2009-01-20 | Therakos, Inc. | Method for collecting a desired blood component and performing a photopheresis treatment |
US7211037B2 (en) * | 2002-03-04 | 2007-05-01 | Therakos, Inc. | Apparatus for the continuous separation of biological fluids into components and method of using same |
US20040127840A1 (en) * | 2002-03-04 | 2004-07-01 | Steve Gara | Blood separation apparatus and method of using the same |
US7186230B2 (en) * | 2002-03-04 | 2007-03-06 | Therakos, Inc | Method and apparatus for the continuous separation of biological fluids into components |
US20050049539A1 (en) * | 2003-09-03 | 2005-03-03 | O'hara Gerald P. | Control system for driving fluids through an extracorporeal blood circuit |
US20050101997A1 (en) * | 2003-11-12 | 2005-05-12 | Reddy Vivek Y. | Arrangements and methods for determining or treating cardiac abnormalities and inconsistencies |
AU2004237844B2 (en) | 2003-12-23 | 2011-01-27 | Therakos, Inc. | Extracorporeal photopheresis in combination with anti-TNF treatment |
US8296071B2 (en) * | 2004-03-15 | 2012-10-23 | Terumo Bct Biotechnologies, Llc | Methods for uniformly treating biological samples with electromagnetic radiation |
US7476209B2 (en) * | 2004-12-21 | 2009-01-13 | Therakos, Inc. | Method and apparatus for collecting a blood component and performing a photopheresis treatment |
DE102005022608B3 (de) * | 2005-05-11 | 2007-01-11 | Karl Storz Gmbh & Co. Kg | Lichtsystem zur photodynamischen Diagnose und/oder Therapie |
EP2796168B1 (de) * | 2005-09-28 | 2017-09-06 | Candela Corporation | Behandlung von Cellulitis |
CA2628341A1 (en) * | 2005-11-02 | 2007-05-18 | Therakos Inc. | The use of apoptotic cells ex vivo to generate regulatory t cells |
US20070264663A1 (en) | 2006-05-02 | 2007-11-15 | O'brien Peter J | Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality |
EP2484378A4 (de) * | 2009-09-30 | 2013-05-22 | Toray Industries | Hepatitis-c-virus-impfstoffzusammensetzung |
US9399093B2 (en) | 2012-01-27 | 2016-07-26 | Fenwal, Inc. | Systems and methods for performing online extracorporeal photopheresis |
WO2014123521A1 (en) | 2013-02-06 | 2014-08-14 | Fenwal, Inc. | Method for delivering desired light dose to cells in a light attenuating medium |
US10172995B2 (en) | 2013-02-06 | 2019-01-08 | Fenwal, Inc. | System and method for determining irradiation exposure time with irradiation sensors during extracorporeal photopheresis |
US10213544B2 (en) | 2013-06-13 | 2019-02-26 | Fenwal, Inc. | Methods for treating a suspension of mononuclear cells to facilitate extracorporeal photopheresis |
GB2525432A (en) * | 2014-04-24 | 2015-10-28 | Univ Oslo Hf | Modification of extracorporeal photopheresis technology with porphyrin precursors |
US20160114095A1 (en) * | 2014-10-27 | 2016-04-28 | Fenwal, Inc. | Methods and systems for collecting mononuclear cells |
JP6632359B2 (ja) * | 2015-01-05 | 2020-01-22 | フェンウォール、インコーポレイテッド | 体外フォトフェレーシスにおいて照射受光部を用いて最小ヘマトクリットを検出するためのシステムと方法 |
EP3552637B1 (de) | 2015-02-06 | 2022-09-28 | Fenwal, Inc. | System zur bestimmung der bestrahlungszeit mit lichtsensoren während der extrakorporalen photopherese |
ES2941353T3 (es) | 2015-06-19 | 2023-05-22 | Mallinckrodt Pharmaceuticals Ireland Ltd | Sistemas de procesamiento de sangre para recoger componentes sanguíneos |
US10434240B2 (en) | 2015-08-17 | 2019-10-08 | Fenwal, Inc. | Methods and systems for processing and washing a photopheresis mononuclear cell product |
GB201604246D0 (en) * | 2016-03-11 | 2016-04-27 | Univ Hull | Radioactivity detection |
US10556053B2 (en) | 2017-01-30 | 2020-02-11 | Fenwal, Inc. | System for collecting mononuclear cells having a suitable hematocrit for extracorporeal photopheresis |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3236999A (en) * | 1962-10-01 | 1966-02-22 | North American Aviation Inc | Computer having floating point division |
US4196281A (en) | 1976-10-20 | 1980-04-01 | Regents Of The University Of California | Psoralens |
US4260630A (en) * | 1977-08-29 | 1981-04-07 | Agence Nationale De Valorisation De La Recherche (Anvar) | Skin diseases |
IT1088554B (it) | 1977-11-17 | 1985-06-10 | F I D I A Spa | Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina |
US4428744A (en) | 1979-12-11 | 1984-01-31 | Frederic A. Bourke, Jr. | Method and system for externally treating the blood |
US4321919A (en) | 1979-12-11 | 1982-03-30 | Leukocyte Research, Inc. | Method and system for externally treating human blood |
US4398906A (en) | 1979-12-11 | 1983-08-16 | Frederic A. Bourke, Jr. | Method for externally treating the blood |
JPS56161054A (en) * | 1980-05-15 | 1981-12-11 | Ushio Electric Inc | Sterilizing method |
US4464166A (en) | 1981-06-12 | 1984-08-07 | Frederic A. Bourke, Jr. | Method for externally treating the blood |
US4612007A (en) | 1981-06-16 | 1986-09-16 | Edelson Richard Leslie | Method and system for externally treating the blood |
FR2521999B1 (fr) | 1982-02-25 | 1984-05-25 | Inst Nat Sante Rech Med | Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant |
FR2521998B1 (fr) | 1982-02-25 | 1985-10-25 | Inst Nat Sante Rech Med | Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant |
US4684521A (en) | 1982-12-08 | 1987-08-04 | Frederic A. Bourke, Jr. | Method and system for externally treating the blood |
US4613322A (en) | 1982-12-08 | 1986-09-23 | Edelson Richard Leslie | Method and system for externally treating the blood |
US4683889A (en) | 1983-03-29 | 1987-08-04 | Frederic A. Bourke, Jr. | Method and system for externally treating the blood |
US5176921A (en) | 1983-05-02 | 1993-01-05 | Diamond Scientific Co. | Method of blood component decontamination by glucose addition |
US4727027A (en) | 1983-05-02 | 1988-02-23 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
US4748120A (en) | 1983-05-02 | 1988-05-31 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
CA1253115A (en) * | 1983-09-29 | 1989-04-25 | Extracorporeal Medical Specialties, Inc. | Apparatus and methods for treating cells with radiation |
US4693981A (en) | 1983-12-20 | 1987-09-15 | Advanced Genetics Research Institute | Preparation of inactivated viral vaccines |
US4737140A (en) | 1984-10-29 | 1988-04-12 | Mcneilab, Inc. | Irradiation chamber for photoactivation patient treatment system |
US4596547A (en) | 1984-10-29 | 1986-06-24 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
US4573962A (en) | 1984-10-29 | 1986-03-04 | Extracorporeal Medical Specialties, Inc. | Cassette drawer assembly for photoactivation patient treatment system |
US4692138A (en) | 1984-10-29 | 1987-09-08 | Mcneilab, Inc. | Pump block for interfacing irradiation chamber to photoactivation patient treatment system |
US4708715A (en) | 1984-10-29 | 1987-11-24 | Mcneilab, Inc. | Light array assembly for photoactivation patient treatment system |
US4578056A (en) | 1984-10-29 | 1986-03-25 | Extracorporeal Medical Specialties, Inc. | Patient photopheresis treatment apparatus and method |
US4573961A (en) | 1984-10-29 | 1986-03-04 | Extracorporeal Medical Specialties, Inc. | Electronic control methods for puvapheresis apparatus |
US4623328A (en) | 1984-10-29 | 1986-11-18 | Mcneilab, Inc. | Pump monitor for photoactivation patient treatment system |
US4568328A (en) | 1984-10-29 | 1986-02-04 | Extracorporeal Medical Specialties, Inc. | Automated photophoresis blood portion control methods and apparatus |
US4573960A (en) | 1984-10-29 | 1986-03-04 | Extracorporeal Medical Specialties, Inc. | Three phase irradiation treatment process |
US4705498A (en) | 1984-10-29 | 1987-11-10 | Mcneilab, Inc. | Disposable temperature probe for photoactivation patient treatment system |
US4643710A (en) | 1984-10-29 | 1987-02-17 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
US4687464A (en) | 1984-10-29 | 1987-08-18 | Mcneilab, Inc. | Zero insertion force socket for photoactivation patient treatment system |
US4681568A (en) | 1984-10-29 | 1987-07-21 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
US4608255A (en) * | 1985-01-31 | 1986-08-26 | American National Red Cross | Biocompatible method for in situ production of functional platelets and product produced thereby lacking immunogenicity |
USD298279S (en) | 1986-02-27 | 1988-10-25 | Mcneilab, Inc. | Disposable patient fluid irradiation chamber |
US4897789A (en) | 1986-02-27 | 1990-01-30 | Mcneilab, Inc. | Electronic device for authenticating and verifying disposable elements |
USD299531S (en) | 1986-02-27 | 1989-01-24 | Mcneilab, Inc. | Patient photopheresis treatment unit |
USD299953S (en) | 1986-02-27 | 1989-02-21 | Mcneilab, Inc. | Control panel for a patient photophoresis treatment unit |
USD298567S (en) | 1986-02-27 | 1988-11-15 | Mcneilab, Inc. | Flexible patient fluid container |
US4726949A (en) | 1986-08-26 | 1988-02-23 | Baxter Travenol Laboratories, Inc. | Irradiation of blood products |
US4952812A (en) | 1986-08-26 | 1990-08-28 | Baxter International Inc. | Irradiation of blood products |
US4866282A (en) | 1986-08-26 | 1989-09-12 | Baxter International Inc. | Irradiation of blood products |
US4838852A (en) | 1987-03-27 | 1989-06-13 | Therakos, Inc. | Active specific immune suppression |
US4878891A (en) | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
DE3739966A1 (de) * | 1987-11-25 | 1989-06-08 | Katadyn Produkte Ag | Vorrichtung zur desinfektion von wasser durch uv-bestrahlung |
DE8815485U1 (de) * | 1988-12-13 | 1990-05-17 | Dr. K. Hoenle Gmbh, 8033 Martinsried, De | |
US4960408A (en) | 1989-01-10 | 1990-10-02 | Klainer Albert S | Treatment methods and vaccines for stimulating an immunological response against retroviruses |
US5216176A (en) | 1989-01-23 | 1993-06-01 | Lehigh University | 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor |
US5356929A (en) | 1989-01-23 | 1994-10-18 | Lehigh University | Reduced and quaternized psoralens as photo-activated therapeutics |
US4921473A (en) | 1989-02-02 | 1990-05-01 | Therakos, Inc. | Multicomponent fluid separation and irradiation system |
US4999375A (en) | 1989-04-11 | 1991-03-12 | Hoffmann-La Roche Inc. | Psoralen reagent compositions for extracorporeal treatment of blood |
ES2110002T3 (es) | 1991-06-21 | 1998-02-01 | Baxter Int | Procedimiento de inactivacion de agentes patogenos en fluidos corporales. |
CA2128866A1 (en) | 1992-01-27 | 1993-08-05 | Raymond P. Goodrich, Jr. | Method of inactivation of viral and bacterial blood contaminants |
CN1022167C (zh) * | 1992-02-21 | 1993-09-22 | 第四军医大学西京医院临床输血研究中心 | 光量子血液治疗仪 |
US5459030A (en) | 1992-03-02 | 1995-10-17 | Steritech, Inc. | Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen |
US5288605A (en) | 1992-03-02 | 1994-02-22 | Steritech, Inc. | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US5618662A (en) * | 1992-03-02 | 1997-04-08 | Cerus Corporation | Intravenous administration of psoralen |
CA2141803C (en) | 1992-08-07 | 2003-06-17 | Lily Lin | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US5651993A (en) | 1992-11-18 | 1997-07-29 | Yale University | Specific immune system modulation |
US5820872A (en) * | 1992-11-18 | 1998-10-13 | Yale University | Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor |
CN1080547A (zh) * | 1993-05-22 | 1994-01-12 | 第四军医大学西京医院临床输血研究中心 | 光量子血液治疗仪 |
US5459322A (en) * | 1993-12-14 | 1995-10-17 | Therakos, Inc. | Ultraviolet light chamber |
US5522868A (en) * | 1994-08-23 | 1996-06-04 | Sisters Of Providence In Oregon | Method and apparatus for determination of psoralen concentrations in biological tissues |
US5925034A (en) * | 1994-08-23 | 1999-07-20 | Sisters Of Providence In Oregon | Method and apparatus for determination of psoralen concentrations in biological tissues |
US5845255A (en) * | 1994-10-28 | 1998-12-01 | Advanced Health Med-E-Systems Corporation | Prescription management system |
CA2235244C (en) * | 1995-10-26 | 2005-03-22 | Purepulse Technologies, Inc. | Improved deactivation of organisms using high-intensity pulsed polychromatic light |
US5768853A (en) * | 1996-02-15 | 1998-06-23 | Purepulse Technologies, Inc. | Deactivation of microorganisms |
BR9708406A (pt) * | 1996-03-29 | 2000-01-04 | Therakos Inc | Tratamento por fotoferese de infecções crÈnicas por hcv. |
CA2250919C (en) | 1996-03-29 | 2008-05-13 | Therakos, Inc. | Photopheresis treatment of leukocytes |
US5922278A (en) * | 1996-11-19 | 1999-07-13 | Baxter International Inc. | Method and apparatus for inactivating contaminants in biological fluid |
JP4180116B2 (ja) | 1996-11-22 | 2008-11-12 | セラコス・インコーポレイテッド | 攬拌を取り入れた血液製剤照射装置 |
-
1999
- 1999-07-09 US US09/350,134 patent/US6219584B1/en not_active Expired - Lifetime
-
2000
- 2000-07-02 IL IL13713300A patent/IL137133A/xx active IP Right Grant
- 2000-07-06 TR TR2000/01913A patent/TR200001913A2/xx unknown
- 2000-07-07 SG SG200003792A patent/SG89337A1/en unknown
- 2000-07-07 HU HU0002591A patent/HUP0002591A2/hu unknown
- 2000-07-07 DE DE60028872T patent/DE60028872T2/de not_active Expired - Lifetime
- 2000-07-07 AT AT00305740T patent/ATE330648T1/de active
- 2000-07-07 EP EP06075929A patent/EP1754497B1/de not_active Expired - Lifetime
- 2000-07-07 JP JP2000207183A patent/JP5008788B2/ja not_active Expired - Lifetime
- 2000-07-07 ES ES00305740T patent/ES2265869T3/es not_active Expired - Lifetime
- 2000-07-07 DK DK00305740T patent/DK1066842T3/da active
- 2000-07-07 DE DE60042349T patent/DE60042349D1/de not_active Expired - Lifetime
- 2000-07-07 AT AT06075929T patent/ATE432725T1/de active
- 2000-07-07 NO NO20003522A patent/NO20003522L/no not_active Application Discontinuation
- 2000-07-07 ES ES06075929T patent/ES2327951T3/es not_active Expired - Lifetime
- 2000-07-07 EP EP00305740A patent/EP1066842B1/de not_active Expired - Lifetime
- 2000-07-07 PT PT00305740T patent/PT1066842E/pt unknown
- 2000-07-07 CZ CZ20002547A patent/CZ302538B6/cs not_active IP Right Cessation
- 2000-07-07 PT PT06075929T patent/PT1754497E/pt unknown
- 2000-07-07 CA CA2313577A patent/CA2313577C/en not_active Expired - Lifetime
- 2000-07-09 CN CNB001269623A patent/CN100354623C/zh not_active Expired - Lifetime
-
2001
- 2001-05-31 HK HK01103770A patent/HK1033101A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2313577A1 (en) | 2001-01-09 |
ES2265869T3 (es) | 2007-03-01 |
IL137133A (en) | 2005-07-25 |
CZ20002547A3 (cs) | 2001-02-14 |
ATE432725T1 (de) | 2009-06-15 |
HUP0002591A2 (hu) | 2001-06-28 |
EP1754497B1 (de) | 2009-06-03 |
EP1754497A1 (de) | 2007-02-21 |
CA2313577C (en) | 2019-02-12 |
PT1754497E (pt) | 2009-07-27 |
TR200001913A2 (tr) | 2001-02-21 |
PT1066842E (pt) | 2006-09-29 |
DE60042349D1 (de) | 2009-07-16 |
DE60028872D1 (de) | 2006-08-03 |
EP1066842B1 (de) | 2006-06-21 |
JP5008788B2 (ja) | 2012-08-22 |
DK1066842T3 (da) | 2006-10-23 |
SG89337A1 (en) | 2002-06-18 |
EP1066842A3 (de) | 2002-07-17 |
CZ302538B6 (cs) | 2011-07-07 |
CN100354623C (zh) | 2007-12-12 |
ATE330648T1 (de) | 2006-07-15 |
DE60028872T2 (de) | 2006-12-28 |
HK1033101A1 (en) | 2001-08-17 |
HU0002591D0 (en) | 2000-08-28 |
EP1066842A2 (de) | 2001-01-10 |
JP2001054579A (ja) | 2001-02-27 |
ES2327951T3 (es) | 2009-11-05 |
CN1296171A (zh) | 2001-05-23 |
IL137133A0 (en) | 2001-07-24 |
NO20003522D0 (no) | 2000-07-07 |
US6219584B1 (en) | 2001-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003522L (no) | Fremgangsmåte og system for å bestemme en virksom mengde av lysenergi å levere til fluider som har target for lysenergien | |
ATE283700T1 (de) | Therapeutische verwendung eines inhibitors des hedgehog signalübertragungsweges | |
TR199800585T2 (xx) | COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar. | |
BR9811006A (pt) | Sequência de dna, cassete de expressão, uso do mesmo, processo para transformar uma planta, planta com um elevado teor em vitamina e, processo para gerar plantas com um elevado teor em vitamina e e para gerar plantas com elevada resistência a inibidores de hppd, sistema de teste, subtância herbicamente ativa, uso de uma planta, e, planta com elevada resistência a inibidores de hppd | |
NO20072576L (no) | CTLA-4 antistoff og aromataseinhibitor eller kombinasjonsbehandling for brystkreft | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
MX9307185A (es) | Derivados de carboxilato de indol que inhiben la biosintesis del leucotrieno y composiciones farmaceuticas que los contienen. | |
ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
BRPI0508699A (pt) | método para estabilizar uma quantidade de energia de laser liberada a um alvo por um dispositivo gerador de laser, e, método e sistema para executar um procedimento de cirurgia de olho a laser | |
AU4559300A (en) | Use of phyllanthus for targeted stimulation of the immune system | |
WO2009070739A3 (en) | Systems, devices, and methods for directly energizing water molecule composition | |
DOP2000000022A (es) | Combinacion de inhibidores de mtp e inhibidores de hmg-coa reductasa y su uso en medicametos. | |
ES2187648T3 (es) | Metodo para la administracion de farmacos para terapia genica. | |
WO2002000183A3 (en) | Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin | |
WO2002076280A3 (en) | Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer | |
WO2002096471A3 (en) | Viral inactivation process using antioxidant | |
WO2003035048A3 (en) | Methods for the treatment of osteoarthritis and compositions thereof | |
AU2606000A (en) | Antisense modulation of x-linked inhibitor of apoptosis expression | |
BR0012135A (pt) | Métodos de tratamento de infecções de fungos com inibidores de enzima sintetase nad | |
MXPA03011186A (es) | Uso de pentraxina ptx3 de cadena larga para tratamiento contra enfermedades tumorales mediadas por fgf-8. | |
SE0302965D0 (sv) | Hämmare av DNA-Metyltransferasisoformer | |
Ayala et al. | 420: Axonogenesis is Present in Preneoplastic Lesions such as High Grade Prostatic Intraepithelial Neoplasia | |
Ferruelo et al. | 421: Effects of Wine Polyphenols on the Expression of Ciclooxygenase-2 and Apoptosis in Androgen-Independent PC-3 Cell Line | |
Wojewódzka et al. | Back nonhomologous end-joining is the target of sirtuin inhibitor | |
Ferguson | The role of thymidylate synthase in modulating sensitivity to chemotherapeutic agents. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |